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Abstract
Background: Maggots of the blowfly Lucilia sericata are used for the treatment of chronic wounds. Earlier we reported
maggot secretions to inhibit pro-inflammatory responses of human monocytes. The aim of this study was to investigate the
effect of maggot secretions on the differentiation of monocytes into pro-inflammatory (MØ-1) and anti-inflammatory/pro-
angiogenic macrophages (MØ-2) as these cells play a central role in wound healing.
Methodology/Principal Findings: Freshly isolated monocytes were incubated with secretions and GM-CSF or M-CSF for 6
days and then stimulated with LPS or LTA for 18 h. The expression of cell surface molecules and the levels of cytokines,
chemokines and growth factors in supernatants were measured. Our results showed secretions to affect monocyte-
macrophage differentiation leading to MØ-1 with a partial MØ-2-like morphology but lacking CD163, which is characteristic
for MØ-2. In response to LPS or LTA, secretions-differentiated MØ-1 produced less pro-inflammatory cytokines (TNF-a, IL-
12p40 and MIF) than control cells. Similar results were observed for MØ-2 when stimulated with low concentrations of LPS.
Furthermore, secretions dose-dependently led to MØ-1 and MØ-2 characterized by an altered chemokine production.
Secretions led to MØ-2, but not MØ-1, producing enhanced levels of the growth factors bFGF and VEGF, as compared to
control cells. The expression of cell-surface receptors involved in LPS/LTA was enhanced by secretions, that of CD86 and
HLA-DR down-regulated, while receptors involved in phagocytosis remained largely unaffected.
Conclusions: Maggot secretions skew the differentiation of monocytes into macrophages away from a pro-inflammatory to
a pro-angiogenic type.
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Introduction
Foot ulcers of patients with diabetes mellitus are associated with
tremendous health care related and social costs [1,2]. It has been
observed that only two-thirds of foot ulcers will heal [3–5]. Healing
of foot ulcers is essential, since a relatively high proportion will
result in amputation, leading to further costs and patient suffering
[6,7]. Sterile larvae -maggots- of the blowfly Lucilia sericata are used
for the treatment of different types of wounds including diabetic
foot ulcers [8–11]. Clinical observations indicate that besides the
removal of necrotized tissue and infectious microorganisms,
maggots actively promote healing of chronic wounds [8,12,13].
Earlier we reported that maggot secretions inhibited the pro-
inflammatory responses of human neutrophils [14] and monocytes
[15] through elevation of cyclic AMP. In response to local factors,
monocytes migrate into the inflamed site where they may
differentiate into macrophages which exhibit either pro-inflam-
matory or anti-inflammatory/pro-angiogenic functions. These
divergent functions of macrophages are dependent mainly on
the macrophage subset which is regulated by cytokines and growth
factors present in the local micro-environment [16]. For example,
monocytes incubated in the presence of granulocyte macrophage-
colony stimulating factor (GM-CSF) develop in pro-inflammatory
macrophages (MØ-1), i.e. fried egg-shaped macrophages display-
ing high IL-12 and low IL-10 production in response to
lipopolysaccharides (LPS), while monocytes incubated with
macrophage-colony stimulating factor (M-CSF) differentiate to
anti-inflammatory/pro-angiogenic macrophages (MØ-2), charac-
terized by a stretched, spindle-like morphology, expression of
CD163, and low IL-12 and high IL-10 production in response to
LPS. Pro-inflammatory macrophages, by secreting cytokines and
chemokines, are responsible for recruiting and activating immune
cells such as neutrophils, monocytes and macrophages involved in
elimination of infectious agents [17]. In addition, these cytokines
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essential for T-cell activation. When the infection is cleared, the
balance shifts form pro-inflammatory macrophages to macro-
phages with anti-inflammatory/pro-angiogenic cytokine and
growth factor activities. These cells are involved in clearance of
apoptotic cells [18,19], neovascularisation and fibroblast and
epidermal cell proliferation [20]. Concurrently, these cells play a
major role in matrix synthesis by secretion of basement membrane
components, such as collagen [21,22].
Diabetic foot wounds are marked by a prolonged and
dysregulated inflammatory phase. The balance between pro-
inflammatory and anti-inflammatory macrophages is disturbed
[23] resulting in an enhanced production and release of pro-
inflammatory cytokines, proteases and reactive oxygen species
which lead to growth factor inactivation and tissue destruction
[24,25]. Therefore, inhibition of pro-inflammatory responses of
these cells may restrict their deleterious effects, whereas the
induction of anti-inflammatory/pro-angiogenic cytokine and
growth factor activities may contribute to wound repair. Based
on the above considerations, the aim of this study was to
investigate the effects of maggot secretions on the differentiation of
monocytes into pro-inflammatory and anti-inflammatory/pro-
angiogenic macrophages. Our findings provide novel insights into
the modes of action of maggot therapy.
Materials and Methods
Maggots and Maggot Secretions
Sterile second- and third-instar larvae of L. sericata were a kind
gift from BioMonde GmbH (Barsbu ¨ttel, Germany). Maggot
secretions were collected as described previously [15]. Prior to
use, sterile preparations of secretions were pooled and centrifuged
at 1,3006g for 5 min at 4uC to remove particulate material.
Subsequently, protein concentrations of the pools were determined
using the Pierce BCA Protein Assay kit (Pierce Biotechnology,
Rockford, IL, USA) according to manufacturer’s instructions.
Isolation of Human Monocytes
Peripheral blood mononuclear cells from healthy donors were
isolated from buffy coats by Ficoll Amidotrizoate (r=1.077 g/ml)
density centrifugation at 7006g for 20 min. Cells from the
interphase were washed three times with PBS (pH 7.4) and
monocytes were purified using anti-CD14-coated Microbeads
(Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) according
to manufacturer’s instructions. Next, cells were centrifuged and
resuspended in RPMI 1640 supplemented with 2 mmol/l
glutamax-I/glutamine, 2 mmol/l penicillin/streptomycin and
10% (vol./vol.) inactivated fetal calf serum (further referred to as
standard medium).
Macrophages
MØ-1 and MØ-2 were obtained by culturing 3610
5 mono-
cytes/ml of standard medium in 24-wells plates in the presence of
respectively 5 ng of recombinant GM-CSF/ml (Biosource,
Camarillo, Ca, USA) or 12.5 ng of recombinant M-CSF/ml
(R&D Systems Europe Ltd., Abingdon, UK). After 6 days,
macrophages were stimulated with LPS (0.01–100 ng/ml; Sigma
Chemical Co., St. Louis, MO, USA), lipoteichoic acid (LTA;
0.01–5 mg/ml; Invivogen, Toulouse, France) or no stimulus
(further referred to as naı ¨ve macrophages). After 18 to 20 h
incubation at 37uC and 5% CO2, supernatants were collected and
stored at 270uC. To investigate the effect of secretions on the
differentiation of monocytes to macrophages, secretions (range
0.35–70 mg/ml) were added to the wells at the start of the culture
and the resulting macrophages are further referred to as
secretions-differentiated macrophages.
Measurement of the Levels of Cytokines, Chemokines
and Growth Factors
The levels in the supernatants of the cell cultures were assessed
using BioSource CytoSet
TM (Biosource Europe, S.A., Belgium)
and Bio-Plex kits (BIO-RAD, Hercules, CA, USA) according to
manufacturer’s instructions.
Flow Cytometry
To verify the differentiation of monocytes into MØ-1 and MØ-
2, macrophages were incubated with phycoerythrin-conjugated
monoclonal antibodies (mAbs) directed against CD163 purchased
from BD Pharmingen
TM (BD BioSciences, Erembodegem,
Belgium). Furthermore, cells were incubated with FITC- or
phycoerythrin-conjugated mAbs directed against CD11b, CD14,
CD32, CD35, CD54, CD64, CD86, HLA-DR and CD206 (BD
Pharmingen
TM, BD BioSciences, Erembodegem, Belgium), CD16
(EuroBioSciences GmbH, Friesoythe, Germany), and CD282
(Toll-like receptor [TLR]-2) and CD284 (TLR-4; Hycult Biotech-
nology, Uden, the Netherlands for both); incubation was in PBS
containing 0.5% (wt/vol.) BSA for 30 min on ice. Analyses were
performed on the FACSCalibur (Becton&Dickinson, La Jolla, CA,
USA) in combination with CellQuest
TM Pro 4.0.2 software. Mean
fluorescence intensities (MFI) of unstained samples were subtract-
ed from the stained samples. MFI’s below 6 are indicated as not
detectable (#2 times MFI unstained samples).
Statistical Analysis
Differences between the values for cells incubated in the
presence of maggot secretions and those for cells incubated with
H2O were analysed using a Wilcoxon test using Graphpad Prism
version 4.02.
Results
Effect of Maggot Secretions on the Differentiation of
Monocytes to Macrophages
Lightmicroscopyrevealed macrophagesthat differentiated under
the influence of GM-CSF to display a ‘fried egg-like’ morphology
(Fig. 1A) whereas the addition of secretions (35 mg/ml) led to MØ-1
(Fig. 1B) that partially obtained a phenotype resembling MØ-2, i.e.
elongated, spindle-like appearance as induced by M-CSF (Fig. 1C).
Secretions enhanced the development of this morphology by M-
CSF differentiated macrophages (Fig. 1D). However, secretions did
not induce CD163 expression on GM-CSF-differentiated macro-
phages, which is a characteristic of MØ-2. In addition, secretions
did not lead to an altered expression of CD163 (mean fluorescence
intensity ,20) on MØ-2.
Further investigations showed secretions to affect macrophage
differentiation resulting in MØ-1 that in response to various
concentrations of LPS produced less IL-12p40 than control
macrophages (Fig. 2A). MØ-2 differentiated in the presence of
secretions produced less IL-12p40 upon stimulation with 0.01 ng
of LPS/ml, whereas 10 and 100 ng/ml led to increased IL-12p40
production compared to control MØ-2 (Fig. 2B). Remarkably, the
production of IL-12p40 by MØ-2 was almost 10 times higher in
response to 0.01 ng of LPS/ml as compared to 100 ng of LPS/ml.
The production of IL-10 by both types of macrophages
differentiated in the presence of secretions did not differ from
that by control macrophages (Fig. 2C and 2D). Taken together,
the above results indicate that maggot secretions affect the
Maggots Affect MØ Development
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the differentiation from one type into the other.
Cytokine Production by Secretions Differentiated
Macrophages
The results showed that maggot secretions dose-dependently
gave rise to MØ-1 with a decreased production of the pro-
inflammatory cytokines IL-12p40, TNF-a, and Macrophage
Migration Inhibitory Factor (MIF) upon LPS stimulation, as
compared to control cells (Table 1), whereas the level of IL-1b
(mean 103 and range 51–150 pg/ml) did not differ (data not
shown). In addition, the LPS-induced production of IL-6 by these
cells was dose-dependently enhanced as was that of the anti-
inflammatory cytokine IL-10 when using small amounts of
secretions. Secretions had no effect on base-line levels of IL-
12p40, TNF-a, IL-10 and IL-1b (data not shown), but 70 mgo f
secretions/ml led to cells with an increased (p,0.005) production
of IL-6 from 37 (range: 0–125) to 128 (range: 6–524) pg/ml and a
decreased (p,0.05) production of MIF from 226 (range: 81–553)
to 65 (range: 0–99) pg/ml.
In agreement with their effects on LPS-stimulated MØ-1,
maggot secretions dose-dependently led to MØ-2 that showed a
reduced production of IL-12p40 and TNF-a when stimulated with
0.01 ng of LPS/ml, as compared to control cells (Table 1). The
levels of these cytokines were dose-dependently altered in the
presence of secretions when stimulated with 100 ng of LPS/ml.
Furthermore, secretions differentiated MØ-2 showed a reduced
MIF production and an increased IL-6 production regardless of
the amount of LPS used. IL-10 production was not altered by
these cells when stimulated with 0.01 ng of LPS/ml, whereas
70 mg of secretions/ml led to cells with decreased IL-10 levels
when stimulated with 100 ng of LPS/ml. IL-1b levels were not
detectable in the supernatants of MØ-2. Secretions had no effect
on base-line levels of TNF-a, IL-12p40 and IL-10 (data not
shown), but 70 mg of secretions/ml led to MØ-2 displaying
increased (p,0.05) production of IL-6 from 8 (range: 0–42) to 31
(range: 0–78) pg/ml and decreased (p,0.005) production of MIF
from 291 (range: 165–567) to 33 (range: 0–106) pg/ml.
Chemokine Production by Secretions Differentiated
Macrophages
As influx of inflammatory cells contributes to excessive
inflammation in chronic wounds, we investigated the chemokine
profile of secretions-differentiated and control macrophages. The
results (Table 2) showed that maggot secretions dose-dependently
gave rise to naı ¨ve and LPS-stimulated MØ-1 and MØ-2 displaying
Figure 1. Light microscopy analysis of the effect secretions on the differentiation of monocytes to macrophages. Monocytes were
differentiated to MØ-1 in the presence of GM-CSF (A) or in the presence of GM-CSF and 35 mg of secretions/ml (B) and their morphology evaluated.
Similarly, monocytes were differentiated to MØ-2 in the presence of M-CSF (C) and in the presence of M-CSF and secretions (D). Results indicated in
days are from a representative experiment.
doi:10.1371/journal.pone.0008071.g001
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PLoS ONE | www.plosone.org 3 November 2009 | Volume 4 | Issue 11 | e8071Figure 2. Cytokine production in response to LPS. We measured the production of IL-12p40 (A,B) and IL-10 (C,D) by control and secretions-
differentiated MØ-1 and MØ-2 in response to a range of LPS. The results, expressed in ng/ml, are means6SEM of 9–10 experiments. Open bars:
control macrophages; filled bars: secretions differentiated macrophages. *p,0.05 for differences from control macrophages.
doi:10.1371/journal.pone.0008071.g002
Table 1. LPS-induced cytokine production by secretions differentiated macrophages.
Control cells Macrophages differentiated in the presence of secretions (mg/mL)
Type MØ LPS (ng/mL) Median (ng/mL) Range (ng/mL) 0.35 3.5 35 70
(%) (%) (%) (%)
IL-12p40 1 100 25 7.6–38.2 7466** 7565** 6869* 3566**
2 0.01 1 0.2–3.7 7264** 7066** 3366** 2263**
2 100 0.2 0.07–0.5 7764** 7167** 176622** 160628*
TNF-a 1 100 51 25.2–131 92658 5 65* 7166** 5369**
2 0.01 2.8 0.9–7.2 9064* 95675 8 66** 3063**
2 100 3.8 2.6–5.8 9765 100669 7 686 3 69*
MIF 1 100 0.2 0.07–0.4 60610* 4267** 1965** 2467**
2 0.01 0.8 0.2–1.1 70613 4969* 1963* 1561*
2 100 0.3 0.08–0.7 87623 35610** 1965** 663**
IL-6 1 100 37 3.4–60.1 10868 135612** 193642** 226652*
2 0.01 1.9 1.5–27.4 12269* 162614** 239628** 208626**
2 100 0.7 0.2–1.4 10668 148614** 427662** 690689**
IL-10 1 100 0.1 0–0.6 132614* 137616* 98616 97615
2 0.01 0.04 0.02–1.3 9368 114613 74612 83614
2 100 0.7 0.2–1.0 10265 101688 7 686 7 69*
The results for the control macrophages are expressed as the median value and range, and are set at 100%. The effect of secretions is expressed as a percentage relative
to the cytokine production by control cells. Results are means6SEM of at least six experiments. Values are significantly (*p,0.05 and **p,0.005) different from those for
macrophages stimulated with LPS.
doi:10.1371/journal.pone.0008071.t001
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1) and IL-8, but decreased production of Macrophage Inflamma-
tory Protein-1b (MIP-1b). Furthermore, the production of
RANTES was reduced by these cells when stimulated with LPS.
RANTES was not detectable (,10 pg/ml) in the supernatants of
naı ¨ve cells, but 70 mg of secretions/ml led to MØ-1 producing 20
(range: 4.5–661) pg/ml and to MØ-2 producing 13 (range: 3–24)
pg/ml of this chemokine.
Growth Factor Production by Secretions Differentiated
Macrophages
Since tissue synthesis and neovascularisation are essential for
wound healing, we investigated the production of growth factors
by macrophages differentiated in the presence of secretions. The
results showed similar levels of basic fibroblast growth factor
(bFGF) and vascular endothelial growth factor (VEGF) in the
supernatants of secretions-differentiated MØ-1 and control cells;
VEGF production by naı ¨ve cells was not detectable (Table 3).
Furthermore, secretions led to MØ-1 showing decreased produc-
tion of platelet derived growth factor (PDGF)-BB upon LPS
stimulation, whereas the production of G-CSF (median: 306 (46–
1060) pg/ml) by these cells did not differ (data not shown); PDGF-
BB and G-CSF were not detectable in supernatants from naı ¨ve
MØ-1. Remarkably, secretions (70 mg/ml) dose-dependently led
to naı ¨ve MØ-1 displaying (p,0.005) reduced levels of GM-CSF
from 665 (range: 22–2505) to 138 (range: 1–1624) pg/ml and
when stimulated with LPS from 556 (range: 62–1969) to 110
(range: 0–1216) pg/ml.
Contrastingly to MØ-1, secretions dose-dependently gave rise to
naı ¨ve and LPS-stimulated MØ-2 with increased production of
bFGF and VEGF. Additionally, 100 ng of LPS/ml induced a
higher production of VEGF by MØ-2 than 0.01 ng of LPS/ml,
while the effect of secretions was higher when these cells when
stimulated with the latter amount of LPS. Furthermore, secretions
gave rise to MØ-2 showing decreased production of PDGF-BB in
response to LPS; no PDGF-BB was detected in the supernatants of
naı ¨ve MØ-2. G-CSF and GM-CSF were not detectable in the
supernatants of MØ-2 (data not shown).
Expression of Cell Surface Receptors on Secretions
Differentiated Macrophages
To further investigate the effect of secretions on the differenti-
ation of monocytes into macrophages, we measured the expression
of cell surface molecules involved in pathogen recognition, opsono-
phagocytosis, cell adhesion and T-cell activation.
The results showed that secretions (35 mg/ml) gave rise to naı ¨ve and
LPS-stimulated MØ-1 and MØ-2 displaying increased expression of
the pathogen-recognition receptors TLR-2 and TLR-4, as compared
to control cells (Table 4). Interestingly, LPS down-regulated the
expression of these two receptors on MØ-1 (p,0.005) but up-regulated
t h e i re x p r e s s i o no nM Ø - 2( p ,0.05). Additionally, CD14 was
completely down-regulated during the differentiation of monocytes
to MØ-1 but remained present on these cells when differentiated in the
presence of secretions. The expression of CD14 on MØ-2 was not
affected. The expression of the mannose receptor CD206 was
increased on secretions differentiated MØ-1, but not on MØ-2.
Table 2. LPS-induced chemokine production by secretions differentiated macrophages.
Control cells Macrophages differentiatedinthe presence ofsecretions (mg/mL)
Type MØ LPS (ng/mL) Median (ng/mL) Range (ng/mL) 0.35 (%) 3.5 (%) 35 (%) 70 (%)
IL-8 1 0 1.0 0.4–6.6 146622 467698* 27616923* 29066996*
1 100 59 21–116 118614 176628* 343672* 338683*
2 0 1.5 0.4–2.2 103615 142610* 5526158* 7166129*
2 0.01 12 6.3–24 110619 149630* 250634* 378666*
2 100 4.5 3.8–7.6 117610 173622* 480667* 7036112*
MCP-1 1 0 0.7 0.2–5.8 166625* 4376160* 9906353* 11276471*
1 100 8.7 3.9–49 135622 208650* 3356256* 368685*
2 0 31 5.9–40 13768* 159612* 318683* 3616106*
2 0.01 63 32–122 111691 6 1 615* 189617* 175610*
2 100 53 9.0–61 134635 157623* 272648** 242642**
MIP-1b 1 0 0.09 0.02–0.5 7165* 4267** 1664** 1464*
1 100 25 1.2–338 118637 68615 28612* 662**
2 0 0.09 0.03–1.3 93645 5 68** 2266** 1765**
2 0.01 48 24–84 87610 5166** 661** 461**
2 100 45 25–75 92666 1 64** 962** 461**
RANTES 1 0 ND
1 100 4.6 2.1–15 129630 79619 28618** 2166**
20 N D
2 0.01 0.5 0.2–1.5 48611** 6268** 4668** 5068*
2 100 2.0 1.2–3.4 90647 8 68* 4764** 3464**
The results for control macrophages are expressed as the median value and range, and are set at 100%. The effect of secretions is expressed as a percentage relative to
the chemokine production by control cells. Results are means6SEM of at least six experiments. Values are significantly (*p,0.05 and **p,0.005) different from those for
macrophages stimulated with LPS. ND: not detectable.
doi:10.1371/journal.pone.0008071.t002
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receptor II, was increased on naı ¨ve and LPS-stimulated MØ-1 and
MØ-2 differentiated in the presence of secretions. Fcc-receptor II
was slightly decreased on naı ¨ve MØ-2. Secretions led to naı ¨ve
MØ-1 showing enhanced expression of complement receptor 1
but no effect was seen on MØ-2 and LPS-stimulated MØ-1. In
addition, the expression of CD11b (complement receptor 3,
together with CD18) was enhanced by secretions differentiated
MØ-1 but not affected on MØ-2. The expression of cell adhesion
receptor ICAM-1 was not affected by secretions. Finally, secretions
led to MØ-1 and MØ-2 with reduced expression of the co-
stimulatory molecule B7.2, and to MØ-2, but not MØ-1, with
decreased expression of HLA-DR.
Cytokine Production by Secretions Differentiated
Macrophages in Response to LTA
The results showed that secretions gave rise to MØ-1 (Fig. 3A)
and MØ-2 (Fig. 3B) displaying reduced levels of IL-12p40, as
Table 3. LPS-induced growth factor production by secretions differentiated macrophages.
Control cells Macrophages differentiated in the presence of secretions (mg/mL)
Type MØ LPS (ng/mL) Median (pg/mL) Range (pg/mL) 0.35 (%) 3.5 (%) 35 (%) 70 (%)
bFGF 1 0 51 0–111 98669 2 612 116625 150636
1 100 58 22–117 97639 8 649 5 671 1 4 68
2 0 34 10–108 170637 199648* 305686* 3726114*
2 0.01 27 14–40 74619 180628* 234644* 288656**
2 100 56 32–107 10964* 130613* 180630* 214642*
VEGF 1 0 ND
1 100 25 0–120 87659 4 68 101616 95620
2 0 99 18–195 172641* 254645** 5456106** 6276108**
2 0.01 90 21–199 126635 8256232* 11686403* 13826579**
2 100 342 225–540 129610* 174618** 415657** 4236103**
PDGF 1 0 ND
1 100 15 8–61 105669 8 697 2 65* 6469*
2 0 20 6–95 115613 102686 2 610* 58616*
2 0.01 49 24–105 63611* 117614 5467** 4064**
2 100 25 13–114 12366 112676 7 63* 5765*
The results for control macrophages are expressed as the median value and range, and are set at 100%. The effect of secretions is expressed as a percentage relative to
the production of growth factors by control cells. Results are means6SEM of at least six experiments. Values are significantly (*p,0.05 and **p,0.005) different from
those for macrophages stimulated with LPS. ND: not detectable.
doi:10.1371/journal.pone.0008071.t003
Table 4. Expression of surface receptors by secretions-differentiated macrophages.
MØ-1 MØ-2
No stimulus LPS (100 ng/mL) No stimulus LPS (0.01 ng/mL) LPS (100 ng/mL)
03 5 mg/mL 0 35 mg/mL 0 35 mg/mL 0 35 mg/mL 0 35 mg/mL
CD282 TLR-2 77661 0 3 612* 40646 2 67* 54646 5 66* 65667 8 68* 72678 6 67*
CD284 TLR-4 50646 8 610* 32634 5 65* 43635 1 64* 55656 6 66** 58656 8 65**
CD14 LPS-R ND 862* ND 1162* 42643 9 624 1 614 1 632 4 623 0 63
CD206 MMR 45665 7 67* 22623 0 63* 32643 6 632 7 643 4 652 4 632 7 64
CD64 FCcRI 22632 3 631 2 621 2 621 0 611 3 621 1 621 3 631 5 631 8 63
CD32 FCcRII 22651 9 631 9 622 4 641 8 4 619 162621* 206623 195626 170618 181618
CD16 FCcRIIIA 9611 7 64* 660.4 1262* 12632 5 68* 25643 7 66* 11632 3 69*
CD35 CR1 23633 0 64* 8619 611 5 611 5 611 2 611 3 618 618 61
CD11b CR3 113623 171640* 80681 1 2 619* 231612 235616 191614 207615 188617 206618
CD54 ICAM-1 156617 192627 374660 355666 365627 385619 9206115 9116134 9346107 8856105
CD86 B7.2 19631 4 62* 105615 3965* 77676 1 66** 35622 9 62* 69664 2 63**
HLA-DR 212636 218634 270640 249641 317642 250625* 233632 201621* 313643 239621*
Results, expressed as the mean fluorescence intensity (MFI), are means6SEM of 6–11 experiments. Values are significantly (*p,0.05 and **p,0.005) different from those
for control cells. ND: not detectable.
doi:10.1371/journal.pone.0008071.t004
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PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e8071Figure 3. Cytokine production in response to LTA. We measured the production of IL-12p40 (A,B), TNF-a (C,D), IL-6 (E,F) and IL-10 (G,H) by
control and secretions-differentiated MØ-1 and MØ-2 induced by a range of LTA. The results, expressed in ng/ml, are means6SEM of 12 experiments.
Open bars: control macrophages; filled bars: secretions differentiated macrophages. *p,0.05 for differences from control macrophages.
doi:10.1371/journal.pone.0008071.g003
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secretions differentiated MØ-1 (Fig. 3C), but not MØ-2 (Fig. 3D),
showed reduced TNF-a production regardless of the amount of
LTA used. In addition, the production of IL-6 was enhanced by
naı ¨ve MØ-1 (Fig. 3E) and by MØ-2 for all conditions (Fig. 3F)
when differentiated in the presence of secretions. Secretions had
no effect on the production of IL-10 by MØ-1 (Fig. 3G) but led to
MØ-2 showing reduced levels of this cytokine when using 1–5 ng
of LTA/ml (Fig. 3H).
Discussion
The main conclusion from the present study is that maggot
secretions skew the monocyte-macrophage differentiation away
from a pro-inflammatory to a pro-angiogenic type. This
conclusion is based on the following observations. First, maggot
secretions dose-dependently led to MØ-1 producing less IL-12p40,
TNF-a and MIF upon LPS stimulation as compared to control
cells. Similar results were obtained for MØ-2 upon stimulation
with low amounts of LPS. These actions of maggot secretions on
the differentiation of macrophages are not limited to stimulation
via TLR-4 as similar effects were observed when stimulated via the
TLR-2 pathway. Interestingly, adding secretions (35 mg/ml) to
fully differentiated macrophages did not lead to a reduced
production of IL-12p40 or TNF-a (data not shown), indicating
that secretions effect the differentiation of the cells. Second,
maggot secretions led to MØ-1 and MØ-2 with a reduced
production of the chemokines MIP-1b, RANTES and PDGF-BB
and an increased production of MCP-1 and IL-8. Based upon
these findings, it is not possible to predict the overall effect of
maggot secretions on migration of leukocytes into the inflamed
site. However, earlier we reported that secretions reduce the
migration of both monocytes [15] and neutrophils [14] irrespec-
tive of the presence of chemokines. Therefore, migration of
leukocytes will likely be reduced in the presence of secretions.
Third, secretions dose-dependently led to MØ-2, but not MØ-1,
with enhanced production of bFGF and VEGF. These growth
factors, together with IL-8, are involved in endothelial cell
migration and proliferation which is essential for angiogenesis
[20,26]. In addition, low amounts of TNF-a, as observed after
exposure of secretions-differentiated macrophages to LPS, are
known to induce angiogenesis as well. The exact roles of the
elevated IL-6 production by secretions-differentiated macrophages
in inflammation and neovascularisation are unclear as this
cytokine often exerts its effects by regulating the production of
other molecules, such as MIP-1 [27], which we did not observe.
Other findings pertain to the effect of maggot secretions on
monocyte-macrophage differentiation with regard to the expres-
sion of cell-surface receptors. First, secretions led to MØ-1 and
MØ-2 with increased expression of TLR2 and TLR4, as
compared to control cells. Additionally, the expression of the
mannose receptor CD206 was increased by secretions-differenti-
ated MØ-1 while the CD14 expression was still detectable on these
cells. These results suggest that secretions-differentiated macro-
phages may become more sensitive to pathogen-associated
molecular patterns, like LPS and LTA. However, we found no
enhanced sensitivity of the cells to these stimuli. Consequently, our
results may be caused by interference of secretions with signal
transduction pathways down stream of receptor activation such as
a transient rise in cAMP [28,29] and is reported for monocytes[15]
and neutrophils [14] after exposure to secretions. Second,
secretions differentiated MØ-1 and MØ-2 displayed enhanced
expression of CD16. Additionally, the expression of CD11b (part
of CR3), involved in both phagocytosis and adhesion to
endothelial cells [30], was enhanced on secretions differentiated
MØ-1. Expression of CD35 (CR1) was enhanced only on naı ¨ve
MØ-1. Together, it will be of interest to investigate whether the
increased expression of above mentioned receptors mediate
phagocytosis of pathogens by macrophages. Third, secretions led
to MØ-1 with decreased expression of the co-stimulatory molecule
B7.2. This may indicate a reduction in MØ-1-induced Th1 cell
proliferation and function [31,32]. As MØ-2 do not support Th1
cell activation, the effect of the secretions-induced decreased
expression of B7.2 and HLA-DR on these cells is not clear.
Together, maggot secretions may effect macrophage T cell
interactions and this will be the subject of further studies.
Another remarkable finding of this study pertains to the
differential effects of LPS on MØ-1 and MØ-2. LPS stimulates
a pro-inflammatory responses in MØ-1 and subsequently down-
regulates the expression of TLR2 and TLR4 on these macro-
phages, which is reported earlier as LPS tolerance [33]. These
tolerized MØ-1 poorly respond to another challenge with LPS,
thus reducing the pro-inflammatory response and preventing
excessive reactions against infection and subsequent detrimental
effects on the surrounding tissue. In contrast, MØ-2 exert anti-
inflammatory and pro-angiogenic activities. However, once the
infection is cleared these cells may have to initiate a swift response
against a starting/recurring infection. Therefore, the increased
expression of TLRs on these cells may act as a positive regulator of
inflammation. In agreement, we found that MØ-2 produce
relatively high levels of pro-inflammatory cytokines upon stimu-
lation with low, physiological amounts of LPS (0.01 or 0.1 ng of
LPS/ml) as compared to high levels of LPS (100 ng/ml). In
addition, MØ-2 produce high levels of chemokines upon LPS
stimulation indicating that these cells can attract many additional
immune cells. Collectively, it would be interesting to further
investigate the differences between these two subsets of macro-
phages and their role in acute and chronic wounds.
What could be the relevance of the present findings? In a
normal wound healing process, resident cells like macrophages
efficiently detect microbial structures and respond to this by
recruiting neutrophils and monocytes to fight off the invading
pathogens. Initially, monocytes may differentiate to pro-inflam-
matory macrophages that regulate the inflammatory process.
When the infection recedes due to removal of pathogens and
cellular debris, the composition of the local environment will
change facilitating differentiation of monocytes to anti-inflamma-
tory/pro-angiogenic macrophages. These cells suppress inflam-
matory responses directly [19,34,35] and indirectly by inducing
regulatory T cells [36] and mediate neovascularisation, cell
proliferation [20] and subsequent matrix synthesis [21,22]
resulting in repair of the wound. In agreement, we found MØ-1
to produce considerable levels of pro-inflammatory cytokines (e.g.
TNF-a, IL-12p40, MIF) whereas MØ-2 produced high levels of
IL-10, bFGF and VEGF. Although pro-inflammatory cytokines
are essential for acute inflammatory responses, they can be
detrimental in chronic wounds were inflammation persists.
Histological data exists showing that parts of chronic wounds seem
to be stuck in different phases of healing, with loss of synchronicity,
which is essential for a rapid healing [37]. Some parts of the wound
that are ready for fibroblast proliferation and epidermal resurfacing
could be damaged by the inflammatory phase still present in other
parts of the wound [38]. Chronic leg ulcers are associated with
elevated expression of pro-inflammatory cytokines, like TNF-a and
MIF, compared to acute wounds [39–41]. These cytokines promote
the production of more pro-inflammatory cytokines [42,43], up-
regulate the synthesis of matrix metalloproteinases and serine
proteases [24,42,44] and activate the reactive oxygen generating
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extracellular matrix destruction [47–49] and inactivation of growth
factors and protease inhibitors [44,50–52]. Our results showed
inhibited production of pro-inflammatory cytokines by macrophag-
es differentiated in the presence of secretions. These actions of
maggots may provide protection against progression towards
ongoing inflammation and tissue destruction by these cells in
chronic wounds and may result in an environment beneficial for
healing. Simultaneously, the increased pro-angiogenic activity of
anti-inflammatorymacrophagesmayinduceneovascularisationand
theconcurrent formationofgranulation tissue.In agreement, others
reported that maggots increase the expression of bFGF in ulcer
tissue [53] and induce the formation of granulation tissue [9,54].
Taken together, the actions of secretions described in this study
contributeto the exitingbeneficial effects of maggots in diabetic foot
ulcers and other chronic wounds unresponsive to conventional
therapies.
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